N4 PHARMA PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.645 GBX | -14.00% |
|
-19.38% | -24.12% |
| 25/04 | N4 Pharma strikes partnership deal for intracellular delivery | AN |
| 23/04 | N4 Pharma loss widens but "great optimism" remains | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 25.66L | - | - | - | - | - | |
| 72TCr | ||||||
| 59TCr | ||||||
| 37TCr | ||||||
| 33TCr | ||||||
| 28TCr |
- Stock Market
- Equities
- ONZ Stock
- Charts N4 Pharma Plc
- Sector Chart
